Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oncolytics Biotech Inc
ONCYCurrent price
0.63 USD
-0.0059 USD (-0.94%)
Last closed
0.91 CAD
Company
www.oncolyticsbiotech.com
ISIN
CA6823108759
Sector
Healthcare
Industry
Biotechnology
Exchange
TO
Capitalization
91 534 892 CAD
Yield for 12 month
-32.09 %
1Y
3Y
5Y
10Y
15Y
ONCY
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada. Address: 322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.71 CADP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-405 603 CAD
Last Year
-394 533 CAD
Current Quarter
–
Last Quarter
-98 633 CAD
Key Figures ONCY
1 year
3 years
5 years
10 years
EBITDA
-36 683 430 CAD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-71.33 %
PEG Ratio
–
Return On Equity TTM
-138.22 %
Wall Street Target Price
9.71 CAD
Revenue TTM
–
Book Value
0.37 CAD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.36 CAD
Diluted Eps TTM
-0.36 CAD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ONCY
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ONCY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– CAD
Last Split Factor
105:1000
Payout Ratio
–
Last Split Date
25.05.2018
Stock Valuation ONCY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.45
Price Book MRQ
10.04
Financials ONCY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ONCY
For 52 weeks
1.11 CAD
2.09 CAD
50 Day MA
1.52 CAD
Shares Short Prior Month
363 986
200 Day MA
1.44 CAD
Short Ratio
2.20
Shares Short
439 367
Short Percent
0.61 %
BeatStart